Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab
BeiGene
BeiGene
Eli Lilly and Company
Herlev Hospital
SCRI Development Innovations, LLC
Herlev Hospital
Gilead Sciences
University of California, Davis
M.D. Anderson Cancer Center
Hoosier Cancer Research Network
Fudan University
Seoul National University Hospital